Assessment of 3D Transperineal Ultrasound Imaging w/ Matrix Array Transducers in Prostate Radiotherapy

Stopped early

Conditions studied: Prostate Cancer

In brief

SPECIFIC STUDY AIMS 1. To evaluate congruence between pelvic anatomical structures segmented on MRI and/or CT scans co-registered with transperineal US scans acquired with an optically and/or electromagnetically tracked matrix array ultrasound transducer. 2. To estimate the achievable accuracy of anatomy tracking based on 3D US matrix-array transducer imaging and grey-level based image registration algorithms.

Key facts

Study ID

NCT02432820

Run by

Stanford University

People needed

7

Starts

2015-04-01

Expected to finish

2016-09-30

Last updated by the study team

2021-06-11

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Men that will undergo prostate radiotherapy as a primary treatment or post-prostatectomy.
• Age 18 or older
• Ability to understand and sign informed consent

You may not qualify if…

• Younger than 18 yrs old
• Inability to provide written and spoken consent.
• Patients with implanted actively controlled devices that may be subject to electromagnetic interference from the UroNav/PervuNav electromagnetic tracking used in the study.

Where it is running

• Stanford University, School of Medicine — Stanford, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.